Drug Manufacturers - General | Healthcare
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripewater name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Human Pharma is involved in the development and commercialization of such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health therapeutic needs. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
Market Cap
18906341376
Current Price
1338.0
52 Week Range
1101.05 - 1893.95
Previous Close
1307.9
Open
1320.0
Industry
Drug Manufacturers - General
Sector
Healthcare
Address
No.6, Cathedral Road, , Chennai, 600086, India
Phone
+91-44281-16108
Fax
+91-44281-16387
Website
https://www.ttkhealthcare.com
Day Low
1311.0
Day High
1364.9
Dividend Yield
0.82
PE Ratio
21.584126
Earnings Per Share
61.99
Beta
0.255
EBITDA
348281984
Book Value
753.857
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. T. T. Raghunathan B.Com. | Executive Chairman | 72 | 1952 |
Mr. S. Kalyanaraman | CEO, MD & Director | 62 | 1962 |
Mr. S. Ranganath Rao | President of Foods Division | 59 | 1965 |
Mr. K. Sunil | President of Heart Valve Division | 61 | 1963 |
Mr. V. K. Srinivasan | Senior Vice President of Finance | 56 | 1968 |
Mr. B. V. K. Durga Prasad | President of Finance & CFO | 63 | 1961 |
Ms. Gowry A. Jaishankar | Deputy GM of Legal, Company Secretary & Compliance Officer | - | - |
Mr. Yogesh Yadav | President of CPD | 57 | 1967 |
Mr. P. A. Venkateswaran | Business Head of Ortho | 53 | 1971 |
Mr. Brijj Balaji Singh | President of Operations (PDD) | 56 | 1968 |
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Healthcare • Drug Manufacturers - General
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.